Breast Cancer Diagnostics Market - Global Industry Analysis

Breast Cancer Diagnostics Market - By Type (Imaging, Blood Tests, Genomic Tests, and Biopsy), By Product (Platform-based and Instrument-Based), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 29-Jul-2021 Category: Biotechnology Report Format : PDF Pages: 130 Report Code: ZMR-6535 Status : Published

The global Breast Cancer Diagnostics market accrued earnings worth approximately 5.1 (USD Billion) in 2020 and is predicted to gain revenue of about 12.5(USD Billion) by 2028, is set to record a CAGR of nearly 8% over the period from 2021 to 2028.

Description

The global Breast Cancer Diagnostics market accrued earnings worth approximately 5.1 (USD Billion) in 2020 and is predicted to gain revenue of about 12.5(USD Billion) by 2028, is set to record a CAGR of nearly 8% over the period from 2021 to 2028. The report offers assessment and analysis of the Breast Cancer Diagnostics market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Report Scope :

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Breast Cancer Diagnostics Market: Synopsis

Cancer cells detection at initial stage can minimize rate of deaths caused due to breast cancer in women. Researchers have studied a large number of breast diagnostics procedures such as mammography, ultrasound, positron emission tomography, computerized topography, biopsy, and magnetic resonance imaging. Nevertheless, these methods have proved to be very costly as well as time-consuming along with not apt for young females. Hence, it has become need of an hour for introducing diagnostic procedures for determining breast cancer tumors or lumps at initial phase. Investigators are focusing on developing biosensors for detecting breast cancer through use of various kinds of biomarkers. Apart from using biosensors & biomarkers, researchers are studying microwave imaging system functionalities to use it as diagnostic tool for breast screening & detecting breast cancer at early stage in coming years. According to NCBI, in recent years microwave imaging methods have been prescribed by doctors as safe & inexpensive alternate tool to mammography for breast cancer diagnosis.  

Breast Cancer Diagnostics Market: Growth Drivers

A substantial decrement in breast-cancer related deaths in countries such as the U.S. from 1975 to 2000 due to constant improvement in breast cancer diagnostic & screening methods will increment breast cancer diagnostics market size in coming years. Early detection of breast cancer will result in increase in survival rates of patients, thereby driving industry trends.  Furthermore, breakthroughs in molecular biology & pharmacology domains for knowing breast cancer and thus facilitating development of new modes of breast cancer treatments will steer expansion of breast cancer diagnostics market in next few years. With biomarker-based screening techniques such as ELISA, radioimmunoassay, fluoroimmunoassay, and immunohistochemistry catering to needs of breast cancer diagnostics, the market is anticipated to gain traction in the upcoming years.

Moreover, favorable government schemes facilitating more breast screening & diagnosis for detecting cancer at initial stage for treating & curing will create lucrative avenues for breast cancer diagnostics industry over 2021-2028. Launching of technologically upgraded products such as direct to consumer testing product for early diagnosis of cancer in patients will contribute substantially to size of breast cancer diagnostics market over forthcoming years.

Global Breast Cancer Diagnostics Market

Regional Landscape

North America To Lead Breast Cancer Diagnostics Market Surge By 2028

The regional market domination over forecast period can be attributed to large number of reputed breast cancer diagnostic centers in the U.S. and Canada. Apart from this, availability of robust diagnostic & screening infrastructure facility in various countries of North America will pave a way for growth of breast cancer diagnostics market in sub-continent. Growing patient awareness about early diagnosis of breast cancer will further shape market development in region over the coming decade.

Competitive Landscape

Key players profiled in study & influencing market revenue include Hologic Inc., Danaher Corporation, QIANGEN N.V., Koninklijke Philips N.V., F. Hoffmann-La Roche Limited,  Argon Medical Devices, Inc., and BD.

The global Breast Cancer Diagnostics Market is segmented as follows:

By Type

  • Imaging
  • Blood Tests
  • Genomic Tests
  • Biopsy

By Product

  • Platform-based
  • Instrument-based

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Breast Cancer Diagnostics Market, 2018–2028(USD Billion)
    • 2.2. Breast Cancer Diagnostics Market: Snapshot
  • Chapter 3. Global Breast Cancer Diagnostics Market– Industry Analysis
    • 3.1. Breast Cancer Diagnostics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. A significant decrease in breast-cancer related demises in countries such as the U.S. from 1975 to 2000 owing to consistent improvement in breast cancer diagnostic procedures will enhance breast cancer diagnostics market expansion within a couple of years.
      • 3.2.2. Early & quick detection of breast cancer tumors or cell tissues will lead to rise in rate of survival of patients through immediate & effective treatment of the disease, thereby embellishing industry space.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Type
      • 3.4.2. Market attractiveness analysis By Product
  • Chapter 4. Global Breast Cancer Diagnostics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Breast Cancer Diagnostics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Technulogy launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Breast Cancer Diagnostics Market– Type Analysis
    • 5.1. Global Breast Cancer Diagnostics Market overview: By Type
      • 5.1.1. Global Breast Cancer Diagnostics Market share, By Type, 2020 and 2028
    • 5.2. Imaging
      • 5.2.1. Global Breast Cancer Diagnostics Market by Imaging, 2018–2028(USD Billion)
    • 5.3. Blood Tests
      • 5.3.1. Global Breast Cancer Diagnostics Market by Blood Tests, 2018–2028(USD Billion)
    • 5.4. Genomic Tests
      • 5.4.1. Global Breast Cancer Diagnostics Market by Genomic Tests, 2018–2028(USD Billion)
    • 5.5. Biopsy
      • 5.5.1. Global Breast Cancer Diagnostics Market by Biopsy, 2018–2028(USD Billion)
  • Chapter 6. Global Breast Cancer Diagnostics Market– Product Analysis
    • 6.1. Global Breast Cancer Diagnostics Market overview: By Product
      • 6.1.1. Global Breast Cancer Diagnostics Market share, By Product, 2020 and 2028
    • 6.2. Platform-based
      • 6.2.1. Global Breast Cancer Diagnostics Market by Platform-based , 2018–2028(USD Billion)
    • 6.3. Instrument-based
      • 6.3.1. Global Breast Cancer Diagnostics Market by Instrument-based, 2018–2028(USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Hulogic Inc.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Technulogy Portfulio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Danaher Corporation
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Technulogy Portfulio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. QIANGEN N.V.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Technulogy Portfulio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Development
    • 7.4. Koninklijke Philips N.V.
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Technulogy Portfulio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Development
    • 7.5. F. Hoffmann-La Roche Limited
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Technulogy Portfulio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Argon Medical Devices, Inc.
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Technulogy Portfulio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. BD
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Technulogy Portfulio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development

Methodology


Frequently Asked Questions

A substantial decrement in breast-cancer related deaths in countries such as the U.S. from 1975 to 2000 due to constant improvement in breast cancer diagnostic & screening methods will increment breast cancer diagnostics market size in coming years. Early detection of breast cancer will result in increase in survival rates of patients, thereby driving industry trends.  Furthermore, breakthroughs in molecular biology & pharmacology domains for knowing breast cancer and thus facilitating development of new modes of breast cancer treatments will steer expansion of breast cancer diagnostics market in next few years. With biomarker-based screening techniques such as ELISA, radioimmunoassay, fluoroimmunoassay, and immunohistochemistry catering to needs of breast cancer diagnostics, the market is anticipated to gain traction in the upcoming years.

Moreover, favorable government schemes facilitating more breast screening & diagnosis for detecting cancer at initial stage for treating & curing will create lucrative avenues for breast cancer diagnostics industry over 2021-2028.   

According to Zion market research report, the global Breast Cancer Diagnostics market accrued earnings worth approximately 5.1 (USD Billion) in 2020 and is predicted to gain revenue of about 12.5(USD Billion) by 2028, is set to record a CAGR of nearly 8% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market revenue over the predicted timeline. The regional market surge is due to huge number of renowned breast cancer diagnostic units in the U.S. and Canada. Apart from this, availability of robust diagnostic & screening infrastructure amenities in various countries of North America will pave a way for growth of breast cancer diagnostics market in sub-continent. Growing patient awareness about early diagnosis of breast cancer will further shape market development in region over the coming decade.   

 

The key market participants include Hologic Inc., Danaher Corporation, QIANGEN N.V., Koninklijke Philips N.V., F. Hoffmann-La Roche Limited, Argon Medical Devices, Inc., and BD.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social